ALNY
Alnylam Pharmaceuticals, Inc.
Stock
$219.72−11.46 (−4.96%)Close Oct 2, 2026
- Operating income, 2025
- $502M
Operating income
Operating income by fiscal year
| Period | Operating income | YoY |
|---|---|---|
| 2025 | $502M | — |
| 2024 | −$177M | — |
| 2023 | −$282M | — |
| 2022 | −$785M | — |
| 2021 | −$709M | — |
| 2020 | −$828M | — |
| 2019 | −$939M | — |
| 2018 | −$815M | — |
| 2017 | −$500M | — |
| 2016 | −$425M | — |
| 2015 | −$296M | — |
| 2014 | −$405M | — |
| 2013 | −$93M | — |
| 2012 | −$129M | — |
| 2011 | −$55M | — |
| 2010 | −$44M | — |
| 2009 | −$48M | — |
| 2008 | −$28M | — |